期刊
FUTURE MICROBIOLOGY
卷 4, 期 2, 页码 181-188出版社
FUTURE MEDICINE LTD
DOI: 10.2217/17460913.4.2.181
关键词
biopharmaceuticals; fermentation; heterologous protein secretion; host cell; recombinant protein; Streptomyces; systems biology; twin arginine
类别
Bacterial systems are widely applied as production platforms for proteins of biopharmaceutical or therapeutic interest and industrial enzymes. Among these prokaryotic systems, streptomycetes are attractive host cells because several strains of these Gram-positive bacteria have a high innate secretion capacity and extensive knowledge on their fermentation is available. A survey of the literature and our own experience suggests that several proteins are secreted to commercially acceptable levels. However, many heterologous proteins, most often of eukaryotic origin, are currently only poorly secreted by this host, indicating the need for further optimization of Streptomyces as a production host. In this review, the considerable efforts and strategies made in recent years aimed at improving streptomycetes as a host for the production of recombinant proteins will be discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据